OCA
MBOT icon

OpenArc Corporate Advisory’s Microbot Medical MBOT Stock Holding History

OpenArc Corporate Advisory’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5K Hold
10,000
– – ﹤0.01% 786
2026
Q1 		$24.1K Buy
+10,000
New +$22.3K ﹤0.01% 711

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

OpenArc Corporate Advisory's MBOT Position: Q2 2026 in Review

OpenArc Corporate Advisory held its Microbot Medical (MBOT) position steady in Q2 2026 at 10,000 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

OpenArc Corporate Advisory first reported a position in MBOT in Q1 2026 and has held it in 2 quarters since. The position peaked at $24.1K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • OpenArc Corporate Advisory held 10,000 shares of Microbot Medical worth $19.5K as of Q2 2026.
  • OpenArc Corporate Advisory left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up ﹤0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #786 holding.
  • OpenArc Corporate Advisory first reported a position in Microbot Medical in Q1 2026 and has held it in 2 quarters since.
  • OpenArc Corporate Advisory's Microbot Medical position peaked at $24.1K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.